ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
XENITRA LIMITED
0.003
0.000
成交量:
- -
成交額:
- -
市值:
1,408.46萬
市盈率:
-2
高:
0.003
開:
0.003
低:
0.003
收:
0.003
52周最高:
0.004
52周最低:
0.002
股本:
46.95億
流通股本:
32.28億
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-0.001
每股收益(LYR):
-0.001
淨資產收益率:
-378.25%
總資產收益率:
-52.11%
市淨率:
55.89
市盈率(LYR):
-2.00
資料載入中...
總覽
公司
新聞
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞
Xenitra與知名非處方藥企簽署1200萬澳元供貨協議
投资观察
·
07/27
Xenitra有限公司現已全資收購福康股份,並獲得運營非處方藥業務所需資產
美股速递
·
04/15
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/XEN.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XEN.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"XEN.AU\",,,,,undefined,":{"symbol":"XEN.AU","market":"AU","secType":"STK","nameCN":"XENITRA LIMITED","latestPrice":0.003,"timestamp":1789107120000,"preClose":0.003,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"XENITRA LIMITED","floatShares":3227708209,"shares":4694858828,"eps":-0.0015,"marketStatus":"休市中","change":0,"latestTime":"09-11 16:12:00 AEST","open":0.003,"high":0.003,"low":0.003,"amount":0,"amplitude":0,"askPrice":0.003,"askSize":2056669,"bidPrice":0.002,"bidSize":36649956,"shortable":3,"etf":0,"ttmEps":-0.0015,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789344000000},"marketStatusCode":7,"adr":0,"listingDate":1773925200000,"exchange":"ASX","adjPreClose":0.003,"openAndCloseTimeList":[[1789084800000,1789106400000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"XEN.AU","preClose":0.003,"auctionPrice":0.003,"auctionVolume":300000,"auction":3,"marketStatus":"盘后竞价","timestamp":1788933600702}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"XEN.AU\",,,,,undefined,":{"symbol":"XEN.AU","floatShares":3227708209,"roa":"-52.11%","roe":"-378.25%","lyrEps":-0.0015,"shares":4694858828,"dividePrice":0,"high":0.003,"amplitude":0,"preClose":0.003,"low":0.003,"week52Low":0.002,"pbRate":"55.89","psRate":"0.69","week52High":0.004,"institutionHeld":0,"latestPrice":0.003,"committee":0.89373,"eps":-0.0015,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.0015,"open":0.003,"prevYearClose":0.003,"prevWeekClose":0.003,"prevMonthClose":0.003,"prevQuarterClose":0.002,"fiveDayClose":0.003,"twentyDayClose":0.003,"sixtyDayClose":0.002},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XEN.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XEN.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XEN.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1176353737","title":"Xenitra與知名非處方藥企簽署1200萬澳元供貨協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1176353737","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176353737?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 09:58","pubTimestamp":1785117515,"startTime":"0","endTime":"0","summary":"据路透社7月27日消息,Xenitra Limited宣布达成一项价值1200万澳元的供货协议,合作方是一家领先的非处方药(OTC)制药企业。\n公司表示,已与康盛股份(Zhe Jiang Kangsheng Co., Ltd.)签署了一份为期三年的药品采购框架协议。所有金额均以澳元计。\nXenitra预计,首批商业订单将在本季度内启动执行,标志着双方合作正式进入实质性阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0070","BK0139","BK0151","BK0118","BK0259","BK7128","BK0014","BK0077","002418","XEN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151205903","title":"Xenitra有限公司現已全資收購福康股份,並獲得運營非處方藥業務所需資產","url":"https://stock-news.laohu8.com/highlight/detail?id=1151205903","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151205903?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 07:22","pubTimestamp":1776208934,"startTime":"0","endTime":"0","summary":"Xenitra有限公司(XEN.AU)近日宣布完成对福康公司100%股权的收购,并同步取得运营非处方药(OTC)业务的关键资产。此次交易标志着该公司正式拓展医药健康领域,通过整合福康现有资源构建完整的非处方药产业链。资产包涵盖生产资质、销售渠道及品牌使用权等核心要素,为Xenitra在快速增长的自我药疗市场建立战略支点。此次收购将强化企业多元经营能力,预计通过协同效应提升整体竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7128","XEN.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/XEN.AU\",params:#limit:6,delay:true,,,undefined,":[]}}